centchroman has been researched along with Neoplasm Metastasis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bora, HK; Khan, S; Lakra, AD; Meeran, SM; Shukla, S; Sinha, S | 1 |
| Agarwal, AK; Gupta, R; Kamboj, VP; Misra, NC; Nigam, PK | 1 |
2 other study(ies) available for centchroman and Neoplasm Metastasis
| Article | Year |
|---|---|
Centchroman suppresses breast cancer metastasis by reversing epithelial-mesenchymal transition via downregulation of HER2/ERK1/2/MMP-9 signaling.
Topics: Animals; Apoptosis; Breast Neoplasms; Cell Line; Cell Line, Tumor; Cell Proliferation; Centchroman; Epithelial-Mesenchymal Transition; Humans; Immunohistochemistry; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred BALB C; Neoplasm Metastasis; Wound Healing | 2015 |
Centchroman--a non-steroidal anti-cancer agent for advanced breast cancer: phase-II study.
Topics: Adult; Aged; Antineoplastic Agents; Benzopyrans; Biomarkers, Tumor; Breast Neoplasms; Centchroman; Drug Evaluation; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Prognosis; Receptors, Estrogen | 1989 |